Biodefense Market, By Product (Smallpox, Anthrax, Radiation/Nuclear, Botulism, Detectors/Triggering Devices, Samplers, Identifiers, Assays, and Reagents), and Geography (North America, Europe, Asia Pacific, Latin America and MEA) Analysis, Share, Trends, Size, & Forecast from 2019 2025
REPORT HIGHLIGHT
Biodefense Market was valued at USD 5.42 billion by 2018, growing with 4.8% CAGR during the forecast period, 2019-2025
Market Dynamics
Biodefense is defined as the actions designed to counter biological threats, and prepare to respond bio-incidents. It also refers to the short term, usually military measures to restore biosecurity. Biodefense constitutes the use of medical measures in order to protect individuals against bioterrorism. Biodefense applied to two distinct target populations that are military combatant (troops in the field), and civilian non-combatant.
The market growth is majorly driven by favorable government initiatives. Organizations such as Centers for Disease Control and Prevention (CDC), the Department of Defense (DoD), Biomedical Advanced Research and Development Authority (BARDA), and the United States Department of Health & Human Services (HHS) are actively working towards medical countermeasures against such biological threats. Such initiatives would, in turn, support the market growth to a great extent. However, strict regulations coupled with high barriers to entry will hamper the market growth to some extent.
Product Takeaway
The product segment is broadly classified into vaccines and biothreat detection devices. Vaccine products are further divided into Smallpox, Anthrax, Radiation/nuclear, Botulism, and others. Anthrax and smallpox are amongst the key areas for R&D activities due to their high potential for destruction. These products are continuing to command the attention of many governments globally, accounting for a significant share of the worldwide market. Of these, anthrax captured the highest revenue share, i.e. over 30% in 2018 owing to the rising investments by the U.S. government for mitigating the anthrax bioterrorism risk. Currently, Anthrax Vaccine Adsorbed (AVA) is the only U.S. FDA licensed anthrax vaccine, commercially available under BioThrax trade name in the U.S. market.
Whereas, biothreat detection devices segment is categorized into detectors/triggering devices, samplers, identifiers, assays, and reagents. Biodefense samplers are primarily used to facilitate biological sampling as well as for the transport packaging, reducing waste and speeding up sampling time.
Regional Takeaway
North America captured the highest share (more than 70%) of the worldwide biodefense market. Rising financial support by the U.S. military and civilian agencies for R&D activities coupled with favorable government policies support the regional growth. For instance, the U.S. government has taken steps to implement an enterprise approach and integrated strategy to combat biological threats. In September 2018. U.S. President Donald J. Trump has suggested implementing a National Biodefense Strategy to effectively prepare for fighting biological threats.
On the other side, developing regions such as the Asia Pacific accounts for significant revenue share. Regional growth is majorly attributed to the rising government support coupled with the growing number of conferences on biosafety. For instance, in September 2019, Asia Pacific Biosafety Association (A-PBA) has organized the 14th Annual Biorisk Conference in Dhaka, Bangladesh. This conference was aimed to discuss proactive steps on biosafety and biosecurity for the sustainable development of a region in the healthcare and agricultural sectors.
Key Vendors Takeaway
Key players operating in the global biodefense market include Achaogen, Inc., Xoma Corporation, Emergent BioSolutions, Inc., SIGA Technologies, Inc., PharmAthene, Inc., Elusys Therapeutics, Inc., Dynavax Technologies, Ichor Medical Systems, Cleveland Biolabs, Dynport Vaccine Company, Nanotherapeutics, Inc., Bavarian Nordic, and Alnylam Pharmaceuticals, Inc.
Companies are actively engaged in mergers and acquisitions to expand their presence in the biodefense industry. For instance, a biopharmaceutical company, “Altimmune” acquired PharmAthene, Inc., a biodefense firm in May 2017. This collaboration is aimed to create a new immunotherapy company focused on developing products for infectious diseases such as anthrax. Such activities would, in turn, help key players to expand their presence in this industry.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
KEY PLAYERS
- Dynavax Technologies
- Xoma Corporation
- Emergent BioSolutions, Inc.
- SIGA Technologies, Inc.
- PharmAthene, Inc.
- Elusys Therapeutics, Inc.
- Dynport Vaccine Company
- Bavarian Nordic
- Ichor Medical Systems
- Cleveland Biolabs
- Nanotherapeutics, Inc.
- Achaogen, Inc.
- Alnylam Pharmaceuticals, Inc.
MARKET, BY PRODUCT
- Vaccines
- Smallpox
- Anthrax
- Radiation/Nuclear
- Botulism
- Biothreat Detection Devices
- Samplers
- Identifiers
- Assays
- Reagents
- Detectors/Triggering Devices
MARKET, BY REGION
- North America
- S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1.BIODEFENSE MARKET OVERVIEW
1.1.Study Scope
1.2.Assumption and Methodology
2.EXECUTIVE SUMMARY
2.1.Market Snippet
2.1.1.Market Snippet by Product
2.1.2.Market Snippet by Region
2.2.Competitive Insights
3.BIODEFENSE KEY MARKET TRENDS
3.1.Market Drivers
3.1.1.Impact Analysis of Market Drivers
3.2.Market Restraints
3.2.1.Impact Analysis of Market Restraints
3.3.Market Opportunities
3.4.Market Future Trends
4.BIODEFENSE INDUSTRY STUDY
4.1.Porter’s Five Forces Analysis
4.2.Marketing Strategy Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis
5.BIODEFENSE MARKET LANDSCAPE
5.1.Market Share Analysis
5.2.Key Innovators
5.3.Breakdown Data, by Key manufacturer
5.3.1.Established Player Analysis
5.3.2.Emerging Player Analysis
6.BIODEFENSE MARKET – BY PRODUCT
6.1.Overview
6.1.1.Segment Share Analysis, By Product, 2018 & 2025 (%)
6.2.Vaccines
6.2.1.Overview
6.2.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.3.Smallpox
6.2.3.1.Overview
6.2.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.4.Anthrax
6.2.4.1.Overview
6.2.4.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.5.Radiation/Nuclear
6.2.5.1.Overview
6.2.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.6.Botulism
6.2.6.1.Overview
6.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.Biothreat Detection Devices
6.3.1.Overview
6.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.3.Samplers
6.3.3.1.Overview
6.3.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.4.Identifiers
6.3.4.1.Overview
6.3.4.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.5.Assays
6.3.5.1.Overview
6.3.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.6.Reagents
6.3.6.1.Overview
6.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.7.Detectors/Triggering Devices
6.3.7.1.Overview
6.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.BIODEFENSE MARKET– BY GEOGRAPHY
7.1.Introduction
7.1.1.Segment Share Analysis, By Region, 2018 & 2025 (%)
7.2.North America
7.2.1.Overview
7.2.2.Key Manufacturers in North America
7.2.3.North America Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
7.2.4.North America Market Size and Forecast, By Product, 2014 – 2025 (US$ Million)
7.2.5.U.S.
7.2.5.1.Overview
7.2.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.2.6.Canada
7.2.6.1.Overview
7.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3.Europe
7.3.1.Overview
7.3.2.Key Manufacturers in Europe
7.3.3.Europe Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
7.3.4.Europe Market Size and Forecast, By Product, 2014 – 2025 (US$ Million)
7.3.5.Germany
7.3.5.1.Overview
7.3.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3.6.Italy
7.3.6.1.Overview
7.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3.7.United Kingdom
7.3.7.1.Overview
7.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3.8.France
7.3.8.1.Overview
7.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3.9.Rest of Europe
7.3.9.1.Overview
7.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4.Asia Pacific (APAC)
7.4.1.Overview
7.4.2.Key Manufacturers in Asia Pacific
7.4.3.Asia Pacific Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
7.4.4.Asia Pacific Market Size and Forecast, By Product, 2014 – 2025 (US$ Million)
7.4.5.India
7.4.5.1.Overview
7.4.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4.6.China
7.4.6.1.Overview
7.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4.7.Japan
7.4.7.1.Overview
7.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4.8.South Korea
7.4.8.1.Overview
7.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4.9.Rest of APAC
7.4.9.1.Overview
7.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5.Latin America
7.5.1.Overview
7.5.2.Key Manufacturers in Latin America
7.5.3.Latin America Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
7.5.4.Latin America Market Size and Forecast, By Product, 2014 – 2025 (US$ Million)
7.5.5.Brazil
7.5.5.1.Overview
7.5.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5.6.Mexico
7.5.6.1.Overview
7.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5.7.Argentina
7.5.7.1.Overview
7.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5.8.Rest of LATAM
7.5.8.1.Overview
7.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.6.Middle East and Africa
7.6.1.Overview
7.6.2.Key Manufacturers in Middle East and Africa
7.6.3.Middle East and Africa Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
7.6.4.Middle East and Africa Market Size and Forecast, By Product, 2014 – 2025 (US$ Million)
7.6.5.Saudi Arabia
7.6.5.1.Overview
7.6.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.6.6.United Arab Emirates
7.6.6.1.Overview
7.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.KEY VENDOR ANALYSIS
8.1.Dynavax Technologies
8.1.1.Company Snapshot
8.1.2.Financial Performance
8.1.3.Product Benchmarking
8.1.4.Strategic Initiatives
8.2.Xoma Corporation
8.3.Emergent BioSolutions, Inc.
8.4.SIGA Technologies, Inc.
8.5.PharmAthene, Inc.
8.6.Elusys Therapeutics, Inc.
8.7.Dynport Vaccine Company
8.8.Bavarian Nordic
8.9.Ichor Medical Systems
8.10.Cleveland Biolabs
8.11.Nanotherapeutics, Inc.
8.12.Achaogen, Inc.
8.13.Alnylam Pharmaceuticals, Inc.
9.360 DEGREE ANALYSTVIEW
10.APPENDIX
10.1.Research Methodology
10.2.References
10.3.Abbreviations
10.4.Disclaimer
10.5.Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Biodefense market: Product Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Product
TABLE Global Biodefense market, by Product 2014-2025 (USD Million)
fTABLE Biodefense market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Biodefense market, by Region 2014-2025 (USD Million)
TABLE North America Biodefense market, by Country, 2014-2025 (USD Million)
TABLE North America Biodefense market, by Product, 2014-2025 (USD Million)
TABLE Europe Biodefense market, by country, 2014-2025 (USD Million)
TABLE Europe Biodefense market, by Product, 2014-2025 (USD Million)
TABLE Asia Pacific Biodefense market, by country, 2014-2025 (USD Million)
TABLE Asia Pacific Biodefense market, by Product, 2014-2025 (USD Million)
TABLE Latin America Biodefense market, by country, 2014-2025 (USD Million)
TABLE Latin America Biodefense market, by Product, 2014-2025 (USD Million)
TABLE Middle East and Africa Biodefense market, by country, 2014-2025 (USD Million)
TABLE Middle East and Africa Biodefense market, by Product, 2014-2025 (USD Million)
List of Figures
FIGURE Biodefense market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Product segment market share analysis, 2018 & 2025
FIGURE Product segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Vaccines market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Smallpox market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Anthrax market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Radiation/Nuclear market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Botulism market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Biothreat Detection Devices market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Samplers market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Identifiers market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Assays market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Reagents market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Detectors/Triggering Devices market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Regional segment market share analysis, 2018 & 2025
FIGURE Regional segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE North America Biodefense market share and leading players, 2018
FIGURE Europe Biodefense market share and leading players, 2018
FIGURE Asia Pacific Biodefense market share and leading players, 2018
FIGURE Latin America Biodefense market share and leading players, 2018
FIGURE Middle East and Africa Biodefense market share and leading players, 2018
FIGURE North America market share analysis by country, 2018
FIGURE U.S. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Canada market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Europe market share analysis by country, 2018
FIGURE Germany market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Spain market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Italy market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE UK market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE France market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of the Europe market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Asia Pacific market share analysis by country, 2018
FIGURE India market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE China market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Japan market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE South Korea market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Singapore market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of APAC market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Latin America market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Latin America market share analysis by country, 2018
FIGURE Brazil market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Mexico market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Argentina market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of LATAM market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Middle East and Africa market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Middle East and Africa market share analysis by country, 2018
FIGURE Saudi Arabia market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE United Arab Emirates market size, forecast and trend analysis, 2014 to 2025 (USD Million)
